Advertisement
The presentation will be delivered at 1:30 PM ET / 5:30 GMT on Wednesday,March 19 at the Loews Miami Beach Hotel in Florida. The webcast can beaccessed through the Investors page on deCODE's website, www.decode.com, andthose interested in listening should log on a few minutes in advance in orderto download any software or complete any sign-in that may be required. Thewebcast will be archived for at least one week.
Advertisement
About deCODE
deCODE is a biopharmaceutical company applying its discoveries in humangenetics to the development of drugs and diagnostics for common diseases.deCODE is a global leader in gene discovery -- our population approach andresources have enabled us to isolate key genes contributing to major publichealth challenges from cardiovascular disease to cancer, genes that areproviding us with drug targets rooted in the basic biology of disease. deCODEis also leveraging its expertise in human genetics and integrated drugdiscovery and development capabilities to offer innovative products andservices in personal genome analysis, DNA-based diagnostics, bioinformatics,genotyping, structural biology, drug discovery and clinical development.deCODE is delivering on the promise of the new genetics(SM). Visit us on theweb at www.decode.com; on our diagnostics website atwww.decodediagnostics.com ; and, for our pioneering personal genome analysisservice, at www.decodeme.com .Contact: deCODE genetics Gisli Arnason +354-570-1825 [email protected]
SOURCE deCODE genetics
